Home / News / FAQ
FAQ

FAQ: Nutriband Inc. Presentation at Noble Capital Markets Emerging Growth Virtual Conference

FaqStaq News - Just the FAQs • June 3, 2025
By FAQstaq Staff
Read Original Article →
FAQ: Nutriband Inc. Presentation at Noble Capital Markets Emerging Growth Virtual Conference

Summary

Nutriband Inc. (NASDAQ: NTRB) announced CEO Gareth Sheridan will present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference, highlighting the company's developments in transdermal pharmaceutical products, including its AVERSA(TM) abuse-deterrent technology.

What is the main topic of Nutriband Inc.’s presentation at the Noble Capital Markets Emerging Growth Virtual Conference?

The main topic is Nutriband Inc.’s developments in transdermal pharmaceutical products, particularly its AVERSA(TM) abuse-deterrent technology, as presented by CEO Gareth Sheridan.

When and where will Nutriband Inc.’s presentation take place?

The presentation is scheduled for Thursday, June 5 at 4 p.m. ET at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference.

How can I access Nutriband Inc.’s presentation?

A webcast of the presentation will be available post-event on Nutriband’s website and Channelchek.com, where it will remain archived for 90 days.

What is AVERSA(TM) technology?

AVERSA(TM) is Nutriband’s abuse-deterrent technology designed to be incorporated into transdermal patches to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Who is presenting on behalf of Nutriband Inc.?

Gareth Sheridan, the CEO of Nutriband Inc., will be presenting at the conference.

What are the benefits of Nutriband’s AVERSA(TM) technology?

The technology aims to enhance the safety of transdermal pharmaceutical products by preventing their abuse and misuse, thereby addressing a significant public health concern.

Where can I find more information about Nutriband Inc.?

More information is available on the company’s website at www.Nutriband.com and in the company’s newsroom at https://ibn.fm/NTRB.

What is the significance of Nutriband Inc.’s participation in this conference?

Participation highlights Nutriband’s commitment to advancing its transdermal pharmaceutical products and engaging with investors and the broader financial community.

Can investors meet with Nutriband Inc. during the conference?

Yes, 1×1 meetings are available for qualified investors during the conference.

What is BioMedWire’s role in this announcement?

BioMedWire is a specialized communications platform that provides news and updates on Nutriband Inc. and other companies in the Biotechnology and Life Sciences sectors.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 110674